Faes Farma, S.A. (LON:0K9H)

London flag London · Delayed Price · Currency is GBP · Price in EUR
5.10
-0.01 (-0.22%)
At close: Jan 19, 2026
49.77%
Market Cap1.37B
Revenue (ttm)498.51M
Net Income (ttm)91.72M
Shares Outn/a
EPS (ttm)0.29
PE Ratio14.98
Forward PE17.71
Dividend0.13 (2.45%)
Ex-Dividend DateJan 8, 2026
Volume2,745
Average Volume7,976
Open5.12
Previous Close5.11
Day's Range5.06 - 5.17
52-Week Range3.27 - 5.48
Beta0.24
RSI49.19
Earnings DateFeb 26, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec... [Read more]

Industry Pharmaceutical Preparations
Founded 1933
Employees 1,775
Stock Exchange London Stock Exchange
Ticker Symbol 0K9H
Full Company Profile

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.

Financial numbers in EUR Financial Statements